
See our conversation with @SuperBugDoc and @DWeissLab on antibiotic heteroresistance: Heteroresistance: Mechanisms, Diagnosis and Clinical Implications youtu.be/qcIcyn1bIHU?si=3-74… via @YouTube

Research focused on understanding and combating antibiotic resistance.

See our conversation with @SuperBugDoc and @DWeissLab on antibiotic heteroresistance: Heteroresistance: Mechanisms, Diagnosis and Clinical Implications youtu.be/qcIcyn1bIHU?si=3-74… via @YouTube


Really proud of @ItGlittersGreen for the amazing work she did on this project. Make sure you come to #IDWeek2024 to hear her exciting investigation of cefiderocol heteroresistance in the @ARLGnetwork Prospective Observational Pseudomonas study.

While population analysis profile, the gold-standard for detecting heteroresistance, is not feasible for the clinical lab, we found correlations between heteroresistance and disk diffusion diameter that could be explored as a useful screening test.

Heteroresistant strains also displayed a shift in the population distribution of MICs after cefiderocol exposure. Using whole genome sequencing we found that isolates with non-susceptible MICs developed mutations in the fptA gene encoding the pyochelin receptor, among others.

Importantly, we also show that the heteroresistant phenotype persists when controlling for inoculum (top panel) and when using iron depleted Muller Hinton broth (bottom panel).

6 of 12 isolates with a frameshift mutation in the pirR response regulator gene were found to be resistant or heteroresistant, while none of the 6 control strains with wild type TBDRs displayed this phenotype.

We used a collection of 498 Pseudomonas isolates from the US and South America collected before the introduction of cefiderocol. We found that mutations in these genes were present in between 5-30% of isolates.

Cefiderocol, a siderophore cephalosporin, uses TonB dependent receptors (TBDRs) for drug uptake. In Pseudomonas, the catechol receptors PirA and PiuA (whose expression is controlled by PirRS) play a major role.

Cefiderocol retains in vitro susceptibility against many MDR-pathogens, including Pseudomonas aeruginosa. In this work, we examined cefiderocol heteroresistance, or the presence of a subpopulation of resistant organisms in an otherwise susceptible background.

Now out from our lab in #AACJournal Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin | Antimicrobial Agents and Chemotherapy journals.asm.org/doi/10.1128…

Our inaugural class of two ID fellowships (General and son o-transplant) at Houston Methodist. Proud director Dr. Bhimraj @HMH_IDfellow @IDSAInfo

Antibiotic resistance is one of the biggest challenges facing medicine. @SuperBugDoc and I profiled the latest in molecular epidemiology, resistance, and emerging treatment approaches for the ESKAPE pathogens, now out in @NatureRevMicro rdcu.be/dJNdl

Also, be sure to check out the excellent editorial written by Adeline Supandy and @DariaVanTyne academic.oup.com/jid/advance…

Many thanks for all who helped with this work, @AntibioticApril, KV, Samie, Ayesha, Sam, @ItGlittersGreen, Melissa, An, Lorena, Chuck, Rutan @UwXulab, @dgarsin, Shamoo lab at Rice, and @SuperBugDoc @HMH_IDfellow

In vivo, constitutive activation of MadRS led to larger cardiac microlesions in a mouse peritonitis infection model, suggesting this system may play an important role in protecting E. faecalis from clearance by the host immune response.